Apex Biotechnology Corp. - Taiwan
Figures in New Taiwan dollars.
2026 2025
Revenue NT$151,037,000 NT$187,262,000
Jan-Apr Revenue NT$670,760,000 NT$746,015,000
Source: Taiwan Stock Exchange This content was automatically published based on data and/or text from the original source. For feedback, write to singaporeeditors@dowjones.com.